Compare ASML & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASML | PFE |
|---|---|---|
| Founded | 1984 | 1849 |
| Country | Netherlands | United States |
| Employees | 44209 | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 507.7B | 155.2B |
| IPO Year | N/A | 2013 |
| Metric | ASML | PFE |
|---|---|---|
| Price | $1,444.03 | $27.30 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 13 |
| Target Price | ★ $1,451.25 | $28.92 |
| AVG Volume (30 Days) | 1.7M | ★ 28.3M |
| Earning Date | 04-15-2026 | 05-05-2026 |
| Dividend Yield | 0.44% | ★ 6.33% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.36 |
| Revenue | N/A | ★ $62,579,000,000.00 |
| Revenue This Year | $17.01 | N/A |
| Revenue Next Year | $18.47 | N/A |
| P/E Ratio | $50.62 | ★ $20.00 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $614.06 | $21.87 |
| 52 Week High | $1,547.22 | $28.75 |
| Indicator | ASML | PFE |
|---|---|---|
| Relative Strength Index (RSI) | 60.01 | 49.04 |
| Support Level | $1,285.49 | $26.34 |
| Resistance Level | $1,520.61 | $27.70 |
| Average True Range (ATR) | 44.72 | 0.57 |
| MACD | 21.00 | -0.08 |
| Stochastic Oscillator | 82.80 | 25.18 |
ASML is the leader in lithography systems for manufacturing semiconductors with 90% market share. Lithography is the process in which a light source is used to expose circuit patterns from a photo mask onto a semiconductor wafer. Lithography allows chipmakers to increase the number of transistors on the same area of silicon, with lithography historically representing a high portion of the cost of making cutting-edge chips. ASML outsources the manufacturing of most of its parts, acting like an assembler. ASML's largest clients are TSMC, Samsung, and Intel.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.